T2 Flashcards

(56 cards)

1
Q

pharmacokinetics

A

what the body does to the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pharmacokinetic parameters

A

absorption
distribution
metabolism
elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

molecular weight

A

MW between 100-1000 readily diffuse
MW >1000 do not and may require facilitated diffusion or active transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lipid solubility

A

lipid soluble drugs (lipophilic) pass through cell membranes more easily than water soluble drugs (hydrophilic)
hydrophilic drugs typically require transporter proteins or channels for facilitated transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

protein binding

A

when a drug is bound to proteins, a large complex forms that is unable to cross cell membranes, only unbound (free) drug molecules can cross

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drugs that exhibit low protein binding are generally

A

more easily transported than highly protein bound drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

drugs with reversible protein binding

A

weaker bonds form drug-protein complex
inactive and unable to cross cell membranes when bound
bonds are not permanent, and drug can be released as free-drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

drugs with irreversible protein binding

A

strong bonds form drug-protein complex
permanently inactive and unlikely to be transported once bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

more non-ionized drug in solution will cause

A

drug absoprtion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

more ionized drug in solution will cause

A

drug accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

non-ionized

A

lipid soluble, able to cross membrane barriers easily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ionized

A

water soluble, poorly crosses membrane barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dissociation constant (pKa)

A

defined as the pH at which the ionized and non-ionized forms are equal, classifies a drug as a weak acid or weak base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pH of the environment determines

A

amount of drug that will be ionized or non-ionized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when pKa of the drug = pH of the environment

A

there are equal amounts of ionized and non-ionized drugs in solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

weak acids and weak bases have better absorption

A

weak acids better in acidic solution
weak bases better in alkaline solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

weak acids and weak bases have better elimination

A

weak acids have better elimination in alkaline solution
weak bases have better elimination in acidic solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

weak acid pH of solution < pKa of the drug

A

drug is more likely to be absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

weak acid pH of solution > pKa of the drug

A

drug more likely to accumulate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

weak base pH of solution < pKa of the drug

A

drug is more likely to accumulate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

weak base pH of solution > pKa of the drug

A

drug is more likely to be absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

paracellular transport

A

passage of solutes and fluids through the intracellular space between adjacent cells
occurs in epithelial and endothelial tissues
tight junctions: specialized protein complexes that seal intercellular space
allow for selective permeability (CNS-blood brain barrier)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

passive diffusion

A

major absorption process for small, lipid-soluble, nonionized medications

24
Q

facilitated diffusion via solute carrier (SLC) transporter

A

used for large, water-soluble, or polar medications
saturable process

25
active transport key characteristics
energy requirement saturability selectivity competitive inhibition
26
primary active transport couples with
ATP hydrolysis
27
ATP binding cassette (ABC) transporters
rely on ATP hydrolysis to actively pump substrate across membranes against the concentration gradient
28
sodium/potassium-ATPase
rely on ATP hydrolysis for ion exchange
29
secondary active transport
transport of one solute is energetically driven by the transport of another solute symporters and antiporters
30
symporters
ions move in the same direction sodium/glucose transporter
31
antiporters
ions move in opposite directions sodium/calciu exchanger
32
routes of administration
oral, IM, IV, inhalation, intranasal, subcutaneous, rectal, transdermal, sublingual
33
route of administration bypassing absorption
intravenous
34
factors impacting absorption
surface area of tissue blood flow to the site of absorption pH of the environment physical state of the drug drug concentration at the site of absorption
35
surface area
greater surface area at the site of administration allows for increased absorption
36
optimum site of oral drug absorption
duodenum due to immense surface area
37
blood supply in terms of transport and distribution
greater blood supply allows for quicker transport of drug from the site of administration into the bloodstream greater blood supply = faster and easier distribution
38
factors impacting rate and extent of distribution
size (MW) and polarity (degree of ionization) of the medication blood supply to tissues degree of protein binding drug volume of distribution
39
organs in order of greatest to least amount of blood flow
liver - 1500 mL/min kidneys - 1100 mL/min muscle - 900 mL/min brain - 800 mL/min heart - 250 mL/min adipose - 250 mL/min
40
protein binding in plasma and tissues
typically reversible but may be irreversible
41
high plasma protein binding =
lower concentration of drug in tissues/site of action only unbound drugs can readily diffuse longer time for elimination may limit drug transport metabolism reduced
42
high tissue protein binding =
accumulation and that tissue can act as a reservoir most common in bone and fat due to limited blood supply may limit elimination
43
volume of distribution
measure of apparent space in the body available to contain drug
44
small Vd
<3L, drug remains mostly in the plasma
45
moderate Vd
> 16L, drug distributes to plasma and interstitial fluids
46
large Vd
> 46L, drug distributes to all body compartments
47
metabolites
usually polar and water-soluble which are more readily eliminated
48
active drug
drug that is active on administration breaks down into inactive or less active metabolites via metabolism
49
prodrug
drug that is inactive on administration but is converted to an active compound via metabolism
50
sites of metabolism
liver: cytochrome P450 enzymes intestines lungs kidneys
51
first pass effect
portal vein delivers blood from the GI tract to the liver before it circulates to the rest of the body once in the liver, metabolism occurs
52
drugs with extensive first-pass effect have
smaller amounts of drug reaching systemic circulation and therefore less drug will reach its target
53
routes of administration that bypass first pass effect
IV IM transdermal sublingual inhalation
54
metabolic reactions phase I
cytochrome P450 enzymes catalyze reaction oxidation, hydrolysis, reduction
55
metabolic reaction phase II
conjugation of medication of metabolite with another compound methyl acetyl sulfa glutathione glucuronic acid
56
routes of excretion
renal (urine) liver (bile) GI tract (feces) lungs (exhalation)